Duncan Stearns

4.3k total citations · 1 hit paper
31 papers, 2.1k citations indexed

About

Duncan Stearns is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Duncan Stearns has authored 31 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Genetics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Duncan Stearns's work include Glioma Diagnosis and Treatment (11 papers), Hedgehog Signaling Pathway Studies (10 papers) and Genomics and Chromatin Dynamics (5 papers). Duncan Stearns is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Hedgehog Signaling Pathway Studies (10 papers) and Genomics and Chromatin Dynamics (5 papers). Duncan Stearns collaborates with scholars based in United States, Switzerland and Canada. Duncan Stearns's co-authors include Charles G. Eberhart, Xing Fan, Jiong Chun, Yue‐Ming Li, William Matsui, Leila Khaki, John J. Letterio, Jill S. Barnholtz‐Sloan, Peter de Blank and Johannes Wolff and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Duncan Stearns

27 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011

2014 385 citations Quinn T. Ostrom, Peter de Blank et al. Neuro-Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Duncan Stearns United States	17	1.1k	765	627	372	293	31	2.1k
Giuseppe Lamorte Italy	22	1.5k 1.3×	526 0.7×	804 1.3×	441 1.2×	179 0.6×	44	2.5k
Fréderic Fina France	27	893 0.8×	719 0.9×	687 1.1×	506 1.4×	258 0.9×	87	2.2k
Brian R. Rood United States	25	983 0.9×	674 0.9×	282 0.4×	273 0.7×	307 1.0×	55	1.7k
Evelina Miele Italy	25	1.5k 1.3×	528 0.7×	426 0.7×	799 2.1×	237 0.8×	121	2.3k
Federica Pisati Italy	28	1.5k 1.3×	674 0.9×	516 0.8×	369 1.0×	123 0.4×	55	2.4k
Beth Coyle United Kingdom	22	1.1k 1.0×	1.0k 1.3×	346 0.6×	378 1.0×	368 1.3×	59	2.1k
Arend Koch Germany	34	1.4k 1.2×	848 1.1×	415 0.7×	421 1.1×	333 1.1×	85	2.6k
Javier S. Castresana Spain	30	1.4k 1.2×	514 0.7×	708 1.1×	592 1.6×	426 1.5×	115	2.3k
Nathalie Baeza France	17	1.2k 1.0×	887 1.2×	431 0.7×	561 1.5×	117 0.4×	28	2.2k
Eric H. Raabe United States	25	1.2k 1.0×	635 0.8×	224 0.4×	467 1.3×	372 1.3×	87	1.8k

Countries citing papers authored by Duncan Stearns

Since Specialization

Citations

This map shows the geographic impact of Duncan Stearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan Stearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan Stearns more than expected).

Fields of papers citing papers by Duncan Stearns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duncan Stearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan Stearns. The network helps show where Duncan Stearns may publish in the future.

Co-authorship network of co-authors of Duncan Stearns

This figure shows the co-authorship network connecting the top 25 collaborators of Duncan Stearns. A scholar is included among the top collaborators of Duncan Stearns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duncan Stearns. Duncan Stearns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stearns, Duncan, et al.. (2023). Exploring Barriers to Pediatric Cancer Clinical Trials: The Role of a Networked, Just-in-Time Study Program. Clinical Therapeutics. 45(11). 1148–1150. 4 indexed citations

Jajosky, Audrey N., Robin Elliott, Duncan Stearns, et al.. (2020). Molecular Profiling of Pediatric and Adult Glioblastoma. American Journal of Clinical Pathology. 155(4). 606–614. 5 indexed citations

Bosler, David, et al.. (2018). Donor skin allograft survival after bone marrow transplantation: Case report and systematic review of the literature☆. Journal of Plastic Reconstructive & Aesthetic Surgery. 72(1). 23–34. 4 indexed citations

Egler, Rachel A., et al.. (2017). Hepatoblastoma in an 11-year-old. Medicine. 96(2). e5858–e5858. 15 indexed citations

Campbell, Brittany, Paola Angelini, Nicholas Light, et al.. (2017). PDTM-21. LARGE SCALE TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE PREDISPOSITION AND REVEALS NOVEL CANDIDATES FOR IMMUNE CHECKPOINT INHIBITION. Neuro-Oncology. 19(suppl_6). vi194–vi194. 1 indexed citations

Manjila, Sunil, et al.. (2016). Mature salivary gland rests within sonic hedgehog–positive medulloblastoma: case report and insights into the molecular genetics and embryopathology of ectopic intracranial salivary gland analogs. Journal of Neurosurgery Pediatrics. 18(6). 708–712. 4 indexed citations

Ostrom, Quinn T., Haley Gittleman, Peter de Blank, et al.. (2015). American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro-Oncology. 18(suppl 1). i1–i50. 197 indexed citations

Stearns, Duncan, et al.. (2014). Persistent Alkalosis in a 12-Year-Old with Medulloblastoma. Annals of the American Thoracic Society. 11(3). 458–461.

Ostrom, Quinn T., Peter de Blank, Carol Kruchko, et al.. (2014). Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011. Neuro-Oncology. 16(suppl_10). x1–x36. 385 indexed citations breakdown →

10.

Sloan, Andrew E., Lisa R. Rogers, Paul G. Fisher, et al.. (2013). Risk of subsequent cancer following a primary CNS tumor. Journal of Neuro-Oncology. 112(2). 285–295. 20 indexed citations

11.

Fiaschetti, Giulio, Deborah Castelletti, Stefan Zoller, et al.. (2011). Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma. Oncogene. 30(25). 2823–2835. 21 indexed citations

12.

Bueren, André O. von, Christoph Oehler, Tarek Shalaby, et al.. (2011). c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer. 11(1). 74–74. 20 indexed citations

13.

Zhou, Limei, Daniel Picard, Young‐Shin Ra, et al.. (2010). Silencing of Thrombospondin-1 Is Critical for Myc-Induced Metastatic Phenotypes in Medulloblastoma. Cancer Research. 70(20). 8199–8210. 47 indexed citations

14.

Bueren, André O. von, Tarek Shalaby, Christoph Oehler‐Jänne, et al.. (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer. 9(1). 10–10. 40 indexed citations

15.

Bar, Eli E. & Duncan Stearns. (2008). New developments in medulloblastoma treatment: the potential of a cyclopamine–lovastatin combination. Expert Opinion on Investigational Drugs. 17(2). 185–195. 14 indexed citations

16.

Bueren, André O. von, Tarek Shalaby, Duncan Stearns, et al.. (2007). Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells. BMC Cancer. 7(1). 19–19. 32 indexed citations

17.

Fan, Xing, William Matsui, Leila Khaki, et al.. (2006). Notch Pathway Inhibition Depletes Stem-like Cells and Blocks Engraftment in Embryonal Brain Tumors. Cancer Research. 66(15). 7445–7452. 480 indexed citations

18.

Su, Xiaohua, Vidya Gopalakrishnan, Duncan Stearns, et al.. (2006). Abnormal Expression of REST/NRSF and Myc in Neural Stem/Progenitor Cells Causes Cerebellar Tumors by Blocking Neuronal Differentiation. Molecular and Cellular Biology. 26(5). 1666–1678. 117 indexed citations

19.

Eberhart, Charles G., John Kratz, Yunyue Wang, et al.. (2004). Histopathological and Molecular Prognostic Markers in Medulloblastoma. Journal of Neuropathology & Experimental Neurology. 63(5). 441–449. 165 indexed citations

20.

Kratz, John, Duncan Stearns, David L. Huso, et al.. (2002). Expression of stabilized β-catenin in differentiated neurons of transgenic mice does not result in tumor formation. BMC Cancer. 2(1). 33–33. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact